U.S. flag

An official website of the United States government

NM_000243.3(MEFV):c.911-12G>A AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 23, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000780407.1

Allele description [Variation Report for NM_000243.3(MEFV):c.911-12G>A]

NM_000243.3(MEFV):c.911-12G>A

Gene:
MEFV:MEFV innate immunity regulator, pyrin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_000243.3(MEFV):c.911-12G>A
HGVS:
  • NC_000016.10:g.3249792C>T
  • NG_007871.1:g.11836G>A
  • NM_000243.3:c.911-12G>AMANE SELECT
  • NM_001198536.2:c.278-12G>A
  • LRG_190t1:c.911-12G>A
  • LRG_190:g.11836G>A
  • NC_000016.9:g.3299792C>T
  • NM_000243.2:c.911-12G>A
Links:
dbSNP: rs372016564
NCBI 1000 Genomes Browser:
rs372016564
Molecular consequence:
  • NM_000243.3:c.911-12G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001198536.2:c.278-12G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000917629Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jan 23, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000917629.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The MEFV c.911-12G>A variant involves the alteration of a non-conserved intronic nucleotide. Mutation taster predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 81/268922 control chromosomes (gnomAD), predominantly observed in the African subpopulation at a frequency of 0.003324 (78/23468). This frequency is lower than the estimated maximal expected allele frequency of a pathogenic MEFV variant (0.0216506). The variant of interest has not, to our knowledge, been reported in affected individuals via publications. In FMF database, this variant has been reported in one patient with recurrent fever without strong evidence for or against pathogenicity. Because of the absence of sufficient clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024